Rapalogs in cancer prevention Anti-aging or anticancer?

被引：64
作者：
Blagosklonny, Mikhail V. [1 ]
机构：
[1] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA
来源：
CANCER BIOLOGY & THERAPY | 2012年 / 13卷 / 14期
关键词：
aging; senescence; geroconversion; gerosuppression; rapamycin; diseases; mTOR; TRANSGENIC MOUSE MODEL; AGE-RELATED DISEASES; HEALTHY LIFE-SPAN; CALORIE RESTRICTION; CELL-CYCLE; SPONTANEOUS TUMORIGENESIS; THERAPEUTIC TARGET; MTOR INHIBITION; KAPOSIS-SARCOMA; PI3K PATHWAY;
D O I：
10.4161/cbt.22859
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Common cancer is an age-related disease. Slow aging is associated with reduced and delayed carcinogenesis. Calorie restriction (CR), the most studied anti-aging intervention, prevents cancer by slowing down the aging process. Evidence is emerging that CR decelerates aging by deactivating MTOR (target of rapamycin). Rapamycin and other rapalogs suppress cellular senescence, slow down aging and postpone age-related diseases including cancer. At the same time, rapalogs are approved for certain cancer treatments. Can cancer prevention be explained by direct targeting of cancer cells? Or does rapamycin prevent cancer indirectly through slowing down the aging process? Increasing evidence points to the latter scenario.
引用
收藏
页码：1349 / 1354
页数：6
相关论文
共 140 条
  • [1] Targeting mTOR for the treatment of AML. New agents and new directions.
    Altman, Jessica K.
    Sassano, Antonella
    Platanias, Leonidas C.
    [J]. ONCOTARGET, 2011, 2 (06) : 510 - 517
  • [2] Health Span Approximates Life Span Among Many Supercentenarians: Compression of Morbidity at the Approximate Limit of Life Span
    Andersen, Stacy L.
    Sebastiani, Paola
    Dworkis, Daniel A.
    Feldman, Lori
    Perls, Thomas T.
    [J]. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2012, 67 (04): : 395 - 405
  • [3] Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice
    Anisimov, Vladimir N.
    Zabezhinski, Mark A.
    Popovich, Irina G.
    Piskunova, Tatiana S.
    Semenchenko, Anna V.
    Tyndyk, Margarita L.
    Yurova, Maria N.
    Rosenfeld, Svetlana V.
    Blagosklonny, Mikhail V.
    [J]. CELL CYCLE, 2011, 10 (24) : 4230 - 4236
  • [4] Rapamycin Extends Maximal Lifespan in Cancer-Prone Mice
    Anisimov, Vladimir N.
    Zabezhinski, Mark A.
    Popovich, Irina G.
    Piskunova, Tatiana S.
    Semenchenko, Anna V.
    Tyndyk, Margarita L.
    Yurova, Maria N.
    Antoch, Marina P.
    Blagosklonny, Mikhail V.
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (05) : 2092 - 2097
  • [5] Identification of Akt-selective cytotoxic compounds that enhance cytotoxic responses to rapamycin
    Barger, Jennifer F.
    Gallo, Catherine A.
    Torni, Kyle A.
    Merk, Lisa
    Seibel, William L.
    Nelson, Sandra
    Plas, David R.
    [J]. CANCER BIOLOGY & THERAPY, 2010, 10 (12) : 1256 - 1261
  • [6] Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-deficient mice
    Berrigan, D
    Perkins, SN
    Haines, DC
    Hursting, SD
    [J]. CARCINOGENESIS, 2002, 23 (05) : 817 - 822
  • [7] The two TORCs and Akt
    Bhaskar, Prashanth T.
    Hay, Nissim
    [J]. DEVELOPMENTAL CELL, 2007, 12 (04) : 487 - 502
  • [8] Pharmacologic synergy between dual phosphoinositide-3-kinase and mammalian target of rapamycin inhibition and 5-Fluorouracil in PIK3CA mutant gastric cancer cells
    Bhattacharya, Bhaskar
    Akram, Mohamed
    Balasubramanian, Indirakumar
    Tam, Kimberley K. Y.
    Koh, King X.
    Yee, Mei Q.
    Soong, Richie
    [J]. CANCER BIOLOGY & THERAPY, 2012, 13 (01) : 34 - 42
  • [9] A longer and healthier life with TOR down-regulation: genetics and drugs
    Bjedov, Ivana
    Partridge, Linda
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2011, 39 : 460 - 465
  • [10] Mechanisms of Life Span Extension by Rapamycin in the Fruit Fly Drosophila melanogaster
    Bjedov, Ivana
    Toivonen, Janne M.
    Kerr, Fiona
    Slack, Cathy
    Jacobson, Jake
    Foley, Andrea
    Partridge, Linda
    [J]. CELL METABOLISM, 2010, 11 (01) : 35 - 46
12345678910